Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely made TPD tactics. Within this review, we deal with equally preclinical experiments and clinical trials to deliver an extensive summary of the safety and medical success of PROTACs and MGDs in hematologic malignancies in the last https://marcelleu752lqw6.bloggazzo.com/profile